Completed trials in Kazakhstan: Trial Insights

Filters: Status: Completed Country / region: Kazakhstan Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2003	2
2005	1
2006	2
2007	1
2008	4
2009	5
2010	6
2011	2
2012	7
2013	7
2014	10
2015	5
2016	12
2017	9
2018	13
2019	7
2020	18
2021	21
2022	10
2023	9
2024	14
2025	4
2026	4

Trials by status
Category	Trials
Completed	174

Top lead sponsors
Category	Trials
Bayer	18
Asfendiyarov Kazakh National Medical University	16
Astana Medical University	9
Karaganda Medical University	9
Columbia University	7
Research Institute for Biological Safety Problems	7
Hoffmann-La Roche	6
Takeda	5
The Society of Bariatric and Metabolic Surgeons of Kazakhstan	5
Abbott Medical Devices	4

Top conditions
Category	Trials
COVID-19	11
Obesity	7
Stroke	5
Breast Neoplasms	4
Cardiovascular Diseases	4
Diabetes Mellitus, Type 2	4
Heart Failure	4
Hypertension	4
Influenza, Human	4
Tuberculosis	4

Trials

Showing 76 to 100 of 174. Each trial links to its page on Pharma Observatory.

Esomeprazole to Reduce Organ Failure in Sepsis NCT03452865Phase 3CompletedUniversità Vita-Salute San RaffaeleStarted 2020
Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory NCT04630327ObservationalCompletedKazakh Medical University of Continuing EducationStarted 2020
Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes. NCT06176443Not applicableCompletedThe Society of Bariatric and Metabolic Surgeons of KazakhstanStarted 2020
Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases NCT05717894Phase 4CompletedNazgul OmarbayevaStarted 2020
Influence of Anesthetics on Clinical Outcome in Mitral and Aortic Valve Replacement in Adults NCT05696509Phase 3CompletedAstana Medical UniversityStarted 2020
Sexual Habits Affect Penis Size in Adulthood NCT05654974ObservationalCompletedUniversity Medical Center, KazakhstanStarted 2019
Efficacy and Safety of Mexidol® in Stroke Therapy NCT06437626Phase 3CompletedPharmasoftStarted 2019
Feasibility Study to Use Biosensing Devices to Monitor PA and Resp. Function in Smokers w and w/o Resp. Symptoms/COPD NCT04081961ObservationalCompletedKazakhstan Academy of Preventive MedicineStarted 2019
Evaluation of the Effectiveness of Vibroacoustic Therapy in the Complex Treatment of Acute Respiratory Failure NCT03911947Not applicableCompletedAstana Medical UniversityStarted 2019
One Anastomosis Gastric Bypass With Excluded Stomach Fundoplication: FundoRing vs Nissen vs OAGB Without Fundoplication NCT04828733Not applicableCompletedThe Society of Bariatric and Metabolic Surgeons of KazakhstanStarted 2019
Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients NCT06952361ObservationalCompletedArdak ArynovStarted 2019
Clinical, Psychological and Genetic Characteristics in Dermatological Patients NCT03831646ObservationalCompletedAstana Medical UniversityStarted 2019
The Sublimated Mare Milk Supplement's Effect on Gut Mucosal Lining After Antibiotics NCT03657836Not applicableCompletedNazarbayev University Medical CenterStarted 2018
Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis NCT03664596Not applicableCompletedMedical Centre Hospital of the President's Affairs Administration, Republic of KazakhstanStarted 2018
A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice NCT03532932ObservationalCompletedTakedaStarted 2018
Increasing MSM in the Continuum of Care in Kazakhstan NCT02786615Not applicableCompletedColumbia UniversityStarted 2018
Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576 NCT03588026Phase 3CompletedAKARI TherapeuticsStarted 2018
Bolus Versus Continuous Infusion of Meropenem NCT03452839Phase 4CompletedUniversità Vita-Salute San RaffaeleStarted 2018
Study of the Life Expectancy of Patients With Metabolic Syndrome After Weight Loss: NCT03667469Not applicableCompletedUniversity Medical Center, KazakhstanStarted 2018
Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB NCT03469349Phase 3CompletedTakedaStarted 2018
Effect of Sublimated Mare Milk Supplement on Gut Microbiome in Psoriasis Patients NCT03594877Not applicableCompletedNazarbayev University Medical CenterStarted 2018
The Sublimated Mare Milk Supplement in Hepatitis C NCT03669835Not applicableCompletedAsfendiyarov Kazakh National Medical UniversityStarted 2018
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer NCT03371017Phase 3CompletedHoffmann-La RocheStarted 2018
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia NCT03824457Phase 4CompletedYuria-PharmStarted 2018
Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis NCT03665519Not applicableCompletedNational Scientific Medical Center, KazakhstanStarted 2018

74 more trials match. See them on Pharma Observatory

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory